Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB2300217	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2023-11-29		Novo Nordisk (China) Pharmaceuticals Co Ltd			view
CYSB2200289	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2022-12-27		Novo Nordisk (China) Pharmaceuticals Co Ltd			view
JYSB2200033	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2022-02-28		Novo Nordisk A/S			view
JYSB2200032	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2022-02-28		Novo Nordisk A/S			view
CYSB2101240	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2021-10-27		Novo Nordisk (China) Pharmaceuticals Co Ltd			view
JYSZ2100524	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	License Renew	2021-07-21					view
JYSZ2100523	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	License Renew	2021-07-21					view
JYSB2000365	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products(1)	Supplementary Application	2020-08-07	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2020-08-17	view
JYSB2000364	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products(1)	Supplementary Application	2020-08-07	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2020-08-17	view
JYSB1700144	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2017-08-21	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2017-09-27	view
JYSB1700128	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2017-07-06	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2017-10-30	view
JYSB1700129	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2017-07-06	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2017-10-30	view
JYSB1200180	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2012-07-13	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2014-03-13	view
JYSB1200181	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2012-07-13	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2014-03-13	view
JXSS0900007	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Import Drug Application	2009-08-05	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2012-02-20	view
JXSS0900008	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Import Drug Application	2009-08-05	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2012-02-20	view
JXSL0600021	门冬胰岛素50注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Chinese Herbal Medicine	Import Drug Application	2006-04-11	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2007-05-21	view